Biodesix Gets Medicare Coverage for VeriStrat NSCLC Test | GenomeWeb

NEW YORK (GenomeWeb News) – Biodesix has secured Medicare coverage for its VeriStrat lung cancer test, the company announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.